The Printed Matter Doctrine: Lost in Communication
Contributed by Knobbe Martens. Originally published on Patexia; republished here as part of the LexDana archive.
Written by: Brandon D. Hupka & Jeremy Anapol
IOENGINE, LLC v. Ingenico Inc.
Before Lourie, Chen, and Stoll. Appeal from the Patent Trial and Appeal Board.
Summary: Claim limitations requiring communications to be “encrypted” or to deliver “program code” were not subject to the printed matter doctrine.
Ingenico filed petitions for inter partes review challenging the validity of many claims in three of IOENGINE’s patents. Ingenico argued that claim limitations requiring “encrypted communications” and “program code” were entitled to no patentable weight under the printed matter doctrine. The Board agreed with Ingenico, finding that these limitations were subject to the printed matter doctrine because they claimed the content of information being communicated. The Board relied on this finding to determine that claims reciting these limitations were anticipated by prior art. IOENGINE appealed.
The Federal Circuit held that the “encrypted communications” and “program code” limitations were not subject to the printed matter doctrine because they were “not being claimed here for the content they communicate.” According to the Federal Circuit, requiring a communication to be “encrypted” specifies the “form” of the communication rather than its “content.” And requiring a communication to contain “program code” also did not specify the communication’s content. Thus, the Federal Circuit reversed the Board’s anticipation holding as to the claims that recited these limitations.
Editor: Sean Murray
More insights
Federal Circuit Affirms Invalidation of Patent for Lack of Enablement of Claims Directed to a Method of Treating a Patient with a Unit Dosage in Wyeth Llc v Astrazeneca Pharmaceuticals Lp
Written by : Eric Furman, Ph.D. and Ashley C. Morales Key Takeaway: Federal Circuit invalidates patent claims directed to a method for treating non-small cell lung cancer through administration of “a unit dosage” of an irreversible epidermal…
When About Becomes Indefinite Federal Circuit Provides Guidance for Life Science Patent Applications Regarding Limits of Approximation in Enviro Tech v Safe Foods
Written by : Jason J. Jardine and Kenneth O. Aruda, Ph.D. Key Takeaway: The term “about” remains useful in biotech and pharmaceutical claims, but only if the patent provides objective guidance about what the term means. Absent that guidance,…
When Any Patent Means No Patent Federal Circuit Reverses Non Specific Verdict
Written by : Brian C. Barnes and Sophia F. Zahn OLLNOVA TECHNOLOGIES LTD. v. ECOBEE TECHNOLOGIES ULC [OPINION] Before Chen , Cunningham, and Stark. Appeal from the United States District Court for the Eastern District of Texas. Summary : A verdict form…